BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 25645281)

  • 1. Trafficking and degradation pathways in pathogenic conversion of prions and prion-like proteins in neurodegenerative diseases.
    Victoria GS; Zurzolo C
    Virus Res; 2015 Sep; 207():146-54. PubMed ID: 25645281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic prions and other human neurodegenerative proteinopathies.
    Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
    Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain proteins that mind metals: a neurodegenerative perspective.
    Brown DR
    Dalton Trans; 2009 Jun; (21):4069-76. PubMed ID: 19452053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Conformationally altered proteins cause neurodegenerative diseases].
    Ingelsson M; Nilsson L; Basun H; Aquilonius SM; Lannfelt L
    Lakartidningen; 2005 Nov 21-27; 102(47):3542-3, 3545-6, 3549 passim. PubMed ID: 16408392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
    Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
    J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
    Costanzo M; Zurzolo C
    Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of crowded physiological environments in prion and prion-like protein aggregation.
    Ma Q; Hu JY; Chen J; Liang Y
    Int J Mol Sci; 2013 Oct; 14(11):21339-52. PubMed ID: 24284393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodegeneration. Could they all be prion diseases?
    Miller G
    Science; 2009 Dec; 326(5958):1337-9. PubMed ID: 19965731
    [No Abstract]   [Full Text] [Related]  

  • 9. Defining the Protein Seeds of Neurodegeneration using Real-Time Quaking-Induced Conversion Assays.
    Manca M; Kraus A
    Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32854212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Prion-like Mechanism in Neurodegenerative Diseases-Current Studies and Future Prospects].
    Tarutani A; Hisanaga SI; Hasegawa M
    Brain Nerve; 2016 Oct; 68(10):1197-1204. PubMed ID: 27703107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodegenerative diseases: expanding the prion concept.
    Walker LC; Jucker M
    Annu Rev Neurosci; 2015 Jul; 38():87-103. PubMed ID: 25840008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological inorganic and bioinorganic chemistry of neurodegeneration based on prion and Alzheimer diseases.
    Brown DR; Kozlowski H
    Dalton Trans; 2004 Jul; (13):1907-17. PubMed ID: 15252577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion and prion-like diseases in animals.
    Aguilar-Calvo P; García C; Espinosa JC; Andreoletti O; Torres JM
    Virus Res; 2015 Sep; 207():82-93. PubMed ID: 25444937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the thermodynamics of copper association with amyloid-β, α-synuclein and prion proteins.
    Hong L; Simon JD
    Metallomics; 2011 Mar; 3(3):262-6. PubMed ID: 21116546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of proteins in neurodegenerative disease].
    Szwed A; Miłowska K
    Postepy Hig Med Dosw (Online); 2012 Apr; 66():187-95. PubMed ID: 22706103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular Models for the Study of Prions.
    Holmes BB; Diamond MI
    Cold Spring Harb Perspect Med; 2017 Feb; 7(2):. PubMed ID: 27815306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease as a member of Prion-like disorders.
    Herva ME; Spillantini MG
    Virus Res; 2015 Sep; 207():38-46. PubMed ID: 25456401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prions: generation and spread versus neurotoxicity.
    Halliday M; Radford H; Mallucci GR
    J Biol Chem; 2014 Jul; 289(29):19862-8. PubMed ID: 24860100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prion 2018 round tables (II): Aβ, tau, α-synuclein… are they prions, prion-like proteins, or what?
    Eraña H
    Prion; 2019 Jan; 13(1):41-45. PubMed ID: 30646820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.